HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 04-04-2009, 07:13 AM   #1
BonnieR
Senior Member
 
BonnieR's Avatar
 
Join Date: Jun 2007
Posts: 2,210
I received 3 opinions before deciding on my treatment. One of the oncologist recommended TCH "without the C"! He thought it was the more difficult of the trio and, as you say, would not be adding much. So that is not unheard of in this situation. I ended up taking all 3 and was okay with it. But I totally identify with her anxiety and dread. Big scary decisions are being made. But trust the process and keep the faith.
__________________
Bonnie

Post menopause
May 2007 Core biopsy, Rt breast
ER+, Pr-, HER2 +++, Grade 3
Ki-67: 90%
"suspicious area" left breast
Bilateral mastectomy, (NED on left) May 2007
Sentinel Node Neg
Stage 1, DCIS with microinvasion, 3 mm, mostly removed during the biopsy....
Femara (discontinued 7/07) Resumed 10/07
OncoType score 36 (July 07)
Began THC 7/26/07 (d/c taxol and carboplatin 10/07)
Began Herceptin alone 10/07
Finished Herceptin July /08
D/C Femara 4/10 (joint pain/trigger thumb!)
5/10 mistakenly dx with lung cancer. Middle rt lobe removed!
Aromasin started 5/10
BonnieR is offline   Reply With Quote
Old 04-04-2009, 08:19 AM   #2
Debbie L.
Senior Member
 
Debbie L.'s Avatar
 
Join Date: Jul 2006
Posts: 463
First, there are not good answers right now to the questions about stage I HER2+ cancers, especially ERPR positive ones. But there are some answers.

Second, while I am fascinated by Adjuvant!, it doesn't address HER2+ cancer. It does not include this important factor in prognosis (although there's a reference page that says it may be about 1.5 relative risk increase). More importantly perhaps, it doesn't include Herceptin in treatment options. So without those two critical pieces of predictive and prognostic information, it's essentially worthless for HER2+ use (imho). I do not blame Peter Ravdin for this - he's waiting for enough information to become available to include HER2. Right now, even his Genomic version of Adjuvant! is unavailable (undergoing revision) so we can't use it and include your wife's oncotypeDX score, either.

So about carboplatin - if you google carboplatin her2 breast cancer, you'll get quite a few hits. Most are studies of advanced bc but the basic principle (carboplatin seems to add some benefit) is still applicable. There are some adjuvant studies (same google, add word "adjuvant") but all the ones that I found were pay-per-view. Here's a few of the advanced bc ones:

http://theoncologist.alphamedpress.o...stract/9/5/518

http://www.medscape.com/viewarticle/446899

You'd probably like to know exactly how much absolute benefit carboplatin might add. I think that's the question to ask the provider who recommended TCH and also the one who does not use carboplatin. You are entitled to know more than just "we like this one better". We'll hope that their information is similar and your wife can make her choice based on the best information that is available.

Good luck, keep us posted.

Debbie Laxague
Debbie L. is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 03:00 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter